Compare CRNT & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRNT | PROF |
|---|---|---|
| Founded | 1996 | N/A |
| Country | Israel | Canada |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.5M | 199.3M |
| IPO Year | 2000 | N/A |
| Metric | CRNT | PROF |
|---|---|---|
| Price | $2.11 | $7.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $5.50 | ★ $11.00 |
| AVG Volume (30 Days) | ★ 693.9K | 103.8K |
| Earning Date | 11-11-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $363,330,000.00 | $14,297,000.00 |
| Revenue This Year | N/A | $64.23 |
| Revenue Next Year | $5.06 | $113.06 |
| P/E Ratio | $131.07 | ★ N/A |
| Revenue Growth | N/A | ★ 67.94 |
| 52 Week Low | $1.82 | $3.76 |
| 52 Week High | $5.73 | $7.99 |
| Indicator | CRNT | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 50.28 | 64.52 |
| Support Level | $1.93 | $6.09 |
| Resistance Level | $2.05 | $7.04 |
| Average True Range (ATR) | 0.08 | 0.42 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 98.18 | 94.70 |
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and wide distribution of its business, providing high-capacity wireless connectivity solutions to markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the key revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.